Tratamiento conservador de la osteoartrosis de cadera con toxina botulínica tipo A

Durán-Hernández, Sofía; Soto-Rodríguez, Juan Francisco; Allen-Bobadilla, Jorge; Durán-Hernández, Nayar; García-Mosco, Pamela.
Gac. méd. Méx ; 155(supl.1): 56-61, dic. 2019. tab
Artículo en Español | LILACS | ID: biblio-1286566

Documentos relacionados

  1. [Tratamiento conservador de la osteoartrosis de cadera con toxina botulínica tipo A].
  2. Osteoarthritis of the hip conservative treatment with type A botulinum toxin.
  3. Digital self-management of hip and knee osteoarthritis and trajectories of work and activity impairments.
  4. Quality of total hip arthroplasty health care based on four years of patient-reported outcomes in the Netherlands.
  5. Clinical phenotypes and prognostic factors in persons with hip osteoarthritis undergoing total hip arthroplasty: protocol for a longitudinal prospective cohort study (HIPPROCLIPS).
  6. The Critical Role of Physical Activity and Weight Management in Knee and Hip Osteoarthritis: A Narrative Review.
  7. Osteoarthritis in 2020 and beyond - Authors' reply.
  8. How does hip osteoarthritis differ from knee osteoarthritis?
  9. Knee and hip osteoarthritis are more alike than different in baseline characteristics and outcomes: a longitudinal study of 32,599 patients participating in supervised education and exercise therapy.
  10. Progressive Resistance Training or Neuromuscular Exercise for Hip Osteoarthritis : A Multicenter Cluster Randomized Controlled Trial.